Atomera Inc

ATOM remains in a Stage 4 decline with price below declining EMAs, persistent lower highs and lows, and extreme oversold conditions. Under our Speculative framework, medium-term bias is bearish and mean reversion is not eligible. However, short-term extension and OS context suggest deferring selling. We will stalk for a relief bounce into the 9 EMA / 21 EMA zone to confirm rejection before executing any sell.

• ↑MST tech engaging two gate-all-around customers, targeting AI/RF markets.
• ↑Q2 revenue guidance of $50K–$100K signals near-term ramp.
• ↓Q1 GAAP net loss of $6.1M unchanged YoY, pressuring margins.